Case Report
Copyright ©2010 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastrointest Pharmacol Ther. Dec 6, 2010; 1(6): 135-136
Published online Dec 6, 2010. doi: 10.4292/wjgpt.v1.i6.135
Intestinal pseudo-obstruction in inactive systemic lupus erythematosus: An unusual finding
Giulia Leonardi, Nicola de Bortoli, Massimo Bellini, Maria Gloria Mumolo, Francesco Costa, Angelo Ricchiuti, Stefano Bombardieri, Santino Marchi
Giulia Leonardi, Nicola de Bortoli, Massimo Bellini, Maria Gloria Mumolo, Francesco Costa, Angelo Ricchiuti, Santino Marchi, Gastroenterology Unit, Cisanello Hospital, University of Pisa, Via Paradisa 2, 56124 Pisa, Italy
Stefano Bombardieri, Reumatology Unit, Hospital of Santa Chiara, University of Pisa, Via Roma, 56126 Pisa, Italy
Author contributions: Mumolo MG and Costa F designed the research; Ricchiuti A performed the research; Bombardieri S and Marchi S analyzed the data; Leonardi G, Bellini M and de Bortoli N wrote the paper.
Correspondence to: Giulia Leonardi, MD, Gastroenterology Unit, Cisanello Hospital, University of Pisa, Via Paradisa 2, 56124 Pisa, Italy. giulialeonardi@alice.it
Telephone: +39-50-997435  Fax: +39-50-997436
Received: February 26, 2010
Revised: September 15, 2010
Accepted: September 22, 2010
Published online: December 6, 2010
Abstract

Chronic intestinal pseudo-obstruction (CIP) is an infrequent complication of an active systemic lupus erythematosus (SLE). We illustrate a case of SLE inactive-related CIP. A 51-year old female with inactive SLE (ECLAM score 2) was hospitalized with postprandial fullness, vomiting, abdominal bloating and abdominal pain. She had had no bowel movements for five days. Plain abdominal X-ray revealed multiple fluid levels and dilated small and large bowel loops with air-fluid levels. Intestinal contrast radiology detected dilated loops. CIP was diagnosed. The patient was treated with prokinetics, octreotide, claritromycin, rifaximin, azathioprine and tegaserod without any clinical improvement. Then methylprednisolone (500 mg iv daily) was started. After the first administration, the patient showed peristaltic movements. A bowel movement was reported after the second administration. A plain abdominal X-ray revealed no air-fluid levels. Steroid therapy was slowly reduced with complete resolution of the symptoms. The patient is still in a good clinical condition. SLE-related CIP is generally reported as a complication of an active disease. In our case, CIP was the only clinical demonstration of the SLE.

Keywords: Chronic intestinal pseudo-obstruction; Systemic lupus erythematosus